Serial 98631177
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98631177
- Mark type
- Design / logo
- Filed
- 03 Jul 2024
- Published for opposition
- 12 Aug 2025
- Attorney of record
- Patrick J. Jennings
Goods and services
- Class 001 — Chemicals: Chemical compounds for scientific or research use in vitro studies to test the effects of potential drug compounds on biological targets; adjuvants for scientific or research use, other than for medical or veterinary purposes; chemical reagents for the delivery of lipids for scientific or research use; chemical compounds for use as standards solutions for use with analytical techniques, namely, mass spectrometry; compounds for scientific or research use, namely, lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labeled lipids, oxidized lipids, sphingolipids, lipid extracts from natural sources, lipids conjugated with modified gold particles; compounds for scientific or research use, namely, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; diagnostic reagents and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; lipids, chemical additives, and excipients for use in the manufacture of pharmaceutical preparations
- Class 005 — Pharmaceuticals: Chemical compounds for pharmaceutical or medical use, namely, drug delivery agents being excipients for small molecule, protein drug delivery, and adjuvants for vaccines; adjuvants for medical use; immunostimulatory compounds for medical use; medical diagnostic reagents; medical diagnostic test strips for the detection of bacterial infections for medical use; isotopes for medical use
- Class 040 — Treatment of materials: Current good manufacturing practice (cGMP) custom manufacture of active agents and additives for others; Current good manufacturing practice (cGMP) custom manufacture of lipids for others; custom manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; custom manufacturing services for others in the field of lipids; providing information on chemical manufacturing relating to lipids and related compounds for scientific and medical research purposes
Owner
- Avanti Polar Lipids, LLC, Alabaster, AL, US
- Avanti Polar Lipids, LLC, Alabaster, AL, US
Prosecution history
- 06 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Aug 2025 — PUBLISHED FOR OPPOSITION
- 06 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Jul 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 01 Jul 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 01 Jul 2025 — FINAL REFUSAL E-MAILED
- 01 Jul 2025 — FINAL REFUSAL WRITTEN
- 13 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED